The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Validation and reliability of a Behcet's Syndrome Activity Scale in Korea

  • Choi, Hyo Jin (Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center) ;
  • Seo, Mi Ryoung (Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center) ;
  • Ryu, Hee Jung (Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center) ;
  • Baek, Han Joo (Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center)
  • Received : 2014.12.23
  • Accepted : 2015.04.30
  • Published : 2016.01.01
⟨ Previous Next ⟩

Abstract

Background/Aims: We prepared a cross-cultural adaptation of the Behcet's Syndrome Activity Scale (BSAS) and evaluated its reliability and validity in Korea. Methods: Fifty patients with Behcet's disease (BD) who attended the Rheumatology Clinic of Gachon University Gil Medical Center were included in this study. The first BSAS questionnaire was administered at each clinic visit, and the second questionnaire was completed at home within 24 hours of the visit. A Behcet's Disease Current Activity Form (BDCAF) and a Behcet's Disease Quality of Life (BDQOL) form were also given to patients. The test-retest reliability was analyzed by intraclass correlation coefficients (ICC). To assess the validity, the total BSAS score was compared with the BDCAF score, the patient/physician global assessment, and the BDQOL by Spearman rank correlation. Results: Twelve males and 38 females were enrolled. The mean age was 48.5 years and the mean disease duration was 6.7 years. Thirty-eight patients (76.0%) returned the questionnaire by mail. For the test-retest reliability, the two assessments were significantly correlated on all 10 items of the BSAS questionnaire (p < 0.05) and the total BSAS score (ICC, 0.925; p < 0.001). The total BSAS score was statistically correlated with the BDQOL, BDCAF, and patient/physician global assessment (p < 0.01). Conclusions: The Korean version of BSAS is a reliable and valid instrument to measure BD activity.

Keywords

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med 1999;341:1284-1291. https://doi.org/10.1056/NEJM199910213411707
  2. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet's disease. Yonsei Med J 2007;48:573-585. https://doi.org/10.3349/ymj.2007.48.4.573
  3. Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ. Behcet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) 1999;38:728-733. https://doi.org/10.1093/rheumatology/38.8.728
  4. Choi HJ, Seo MR, Ryu HJ, Baek HJ. Cross-cultural adaptation and validation of the Behcet's Disease Current Activity Form in Korea. Korean J Intern Med 2015;30:714-718. https://doi.org/10.3904/kjim.2015.30.5.714
  5. Forbees C, Swearingen C, Yazici Y. Behcet's syndrome activity score (BSAS): a new disease activity assessment tool, composed of patient-derived measures only, is strongly correlated with the Behcet's Disease Current Activity Form (BDCAF). Arthritis Rheum 2008;58(Suppl 9):S854-S855. https://doi.org/10.1002/art.23225
  6. Yilmaz S, Simsek I, Cinar M, et al. Patient-driven assessment of disease activity in Behcet's syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Behcet's Syndrome Activity Score. Clin Exp Rheumatol 2013;31(3 Suppl 77):77-83.
  7. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990;335:1078-1080.
  8. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25:3186-3191. https://doi.org/10.1097/00007632-200012150-00014
  9. Yi SW, Kim JH, Lim KY, Bang D, Lee S, Lee ES. The Behcet's Disease Quality of Life: reliability and validity of the Korean version. Yonsei Med J 2008;49:698-704. https://doi.org/10.3349/ymj.2008.49.5.698
  10. Castrejon I, Pincus T. Patient self-report outcomes to guide a treat-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis. Clin Exp Rheumatol 2012;30(4 Suppl 73):S50-S55.
  11. Pincus T, Yazici Y, Bergman MJ. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am 2009;35:773-778. https://doi.org/10.1016/j.rdc.2009.10.008

Cited by

  1. Behçet's Disease Current Activity Form as a Patient's Derived Measure vol.23, pp.1, 2016, https://doi.org/10.4078/jrd.2016.23.1.19
  2. CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet’s disease vol.7, pp.None, 2017, https://doi.org/10.1038/s41598-017-15189-9
  3. Choroidal Thickness Indicates Subclinical Ocular and Systemic Inflammation in Eyes with Behçet Disease without Active Inflammation vol.32, pp.4, 2016, https://doi.org/10.3341/kjo.2017.0139
  4. Quality of Life Assessment in Patients with Behçet’s Disease using the Persian Version of the Leeds BD-QoL Questionnaire vol.45, pp.5, 2016, https://doi.org/10.30476/ijms.2020.72634.0